Revealing the genomic heterogeneity of melanoma

Slides:



Advertisements
Similar presentations
Gain of function of mutant p53: The mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation Silvia Di Agostino,
Advertisements

Individualized Medicine from Prewomb to Tomb Eric J. Topol Cell Volume 157, Issue 1, Pages (March 2014) DOI: /j.cell Copyright.
The RAG Recombinase Dictates Functional Heterogeneity and Cellular Fitness in Natural Killer Cells Jenny M. Karo, David G. Schatz, Joseph C. Sun Cell Volume.
What We Talk About When We Talk About Fat Evan D. Rosen, Bruce M. Spiegelman Cell Volume 156, Issue 1, Pages (January 2014) DOI: /j.cell
Origins of Metastatic Traits Sakari Vanharanta, Joan Massagué Cancer Cell Volume 24, Issue 4, Pages (October 2013) DOI: /j.ccr
Maintaining Cell Identity through Global Control of Genomic Organization Gioacchino Natoli Immunity Volume 33, Issue 1, Pages (July 2010) DOI: /j.immuni
Tumor-Derived Jagged1 Promotes Osteolytic Bone Metastasis of Breast Cancer by Engaging Notch Signaling in Bone Cells Nilay Sethi, Xudong Dai, Christopher.
Altered Microenvironmental Regulation of Leukemic and Normal Stem Cells in Chronic Myelogenous Leukemia Bin Zhang, Yin Wei Ho, Qin Huang, Takahiro Maeda,
Evolution of the Cancer Stem Cell Model Antonija Kreso, John E. Dick Cell Stem Cell Volume 14, Issue 3, Pages (March 2014) DOI: /j.stem
ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics Carlos L. Arteaga, Jeffrey A. Engelman Cancer Cell Volume.
Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia Tim C.P. Somervaille, Michael L. Cleary Cancer Cell.
The Landscape of Microsatellite Instability in Colorectal and Endometrial Cancer Genomes Tae-Min Kim, Peter W. Laird, Peter J. Park Cell Volume 155, Issue.
Fate Restriction and Multipotency in Retinal Stem Cells Lázaro Centanin, Burkhard Hoeckendorf, Joachim Wittbrodt Cell Stem Cell Volume 9, Issue 6, Pages.
CDK Inhibitors: Cell Cycle Regulators and Beyond Arnaud Besson, Steven F. Dowdy, James M. Roberts Developmental Cell Volume 14, Issue 2, Pages
The Mitochondrial Basis of Aging Nuo Sun, Richard J. Youle, Toren Finkel Molecular Cell Volume 61, Issue 5, Pages (March 2016) DOI: /j.molcel
UV Light Damages DNA
Shaping Genetic Alterations in Human Cancer: The p53 Mutation Paradigm Thierry Soussi, Klas G. Wiman Cancer Cell Volume 12, Issue 4, Pages (October.
A Conditional Mouse Model of Synovial Sarcoma: Insights into a Myogenic Origin Malay Haldar, Jeffrey D. Hancock, Cheryl M. Coffin, Stephen L. Lessnick,
New Views into the Prostate Cancer Genome
The Kinase-Independent, Second Life of CDK6 in Transcription
Charles Swanton, Julian Downward  Cancer Cell 
The Metastasis Problem Gets Stickier
“Ring-Fencing” BRCA1 Tumor Suppressor Activity
Wild-Type RAS: Keeping Mutant RAS in CHK
Jens T. Siveke, Roland M. Schmid  Cancer Cell 
Mutant p53 gain of function: The NF-Y connection
Volume 9, Issue 6, Pages (June 2006)
Not So Fast: Cultivating miRs as Kinks in the Chain of the Cell Cycle
RAS’s Cloak of Invincibility Slips at Last?
RAS unplugged: Negative feedback and oncogene-induced senescence
George-Lucian Moldovan, Alan D. D'Andrea  Cancer Cell 
MDS Is a Stem Cell Disorder After All
Maria S. Soengas, E. Elizabeth Patton  Cell Stem Cell 
“Ring-Fencing” BRCA1 Tumor Suppressor Activity
DAISY: Picking Synthetic Lethals from Cancer Genomes
Volume 26, Issue 1, Pages 1-2 (July 2014)
Kidney Cancer: Now Available in a New Flavor
Skin-Derived Vitamin D3 Protects against Basal Cell Carcinoma
Volume 13, Issue 1, Pages 1-2 (January 2008)
The AML Salad Bowl Cancer Cell
Volume 9, Issue 6, Pages (June 2006)
Cécile L. Maire, Keith L. Ligon  Cancer Cell 
PICS-ure This: Prosenescence Therapy?
Marguerite Stas, Hugo Degreef  Journal of Investigative Dermatology 
PHIPing Out: A Genetic Basis for Tumor Ulceration
Field Cancerization: Something New Under the Sun
Characterizing the Killer Colorectal Carcinomas
Robert S. Stern  Journal of Investigative Dermatology 
The RAF Inhibitor Paradox Revisited
High Levels of Ultraviolet B Exposure Increase the Risk of Non-Melanoma Skin Cancer in Psoralen and Ultraviolet A-Treated Patients  Jean Lee Lim, Robert.
Mapping Cancer Origins
Hard Times for Oncogenic BRAF-Expressing Melanoma Cells
Volume 143, Issue 6, (December 2010)
Scott A. Foster, Christiaan Klijn, Shiva Malek  Trends in Cancer 
Inferring Tumor Phylogenies from Multi-region Sequencing
Genome-Wide SNP Analysis in Cancer: Leukemia Shows the Way
Varying Mutational Alterations in Multiple Primary Melanomas
MicroRNA-155 Function in B Cells
Squamous Cell Cancers: A Unified Perspective on Biology and Genetics
A common pathway for genetic events leading to pheochromocytoma
Mutant BRAF Melanomas—Dependence and Resistance
To Infinium, and Beyond! Cancer Cell
Volume 10, Issue 3, Pages (September 2006)
The TRIP from ULF to ARF Cancer Cell
There's a Time and a Place for MYCN
Ibrutinib Treatment of CLL: The Cancer Fights Back
Volume 12, Issue 6, Pages (December 2007)
Kidney Cancer: Now Available in a New Flavor
The AML Salad Bowl Cancer Cell
Presentation transcript:

Revealing the genomic heterogeneity of melanoma Omar Kabbarah, Lynda Chin  Cancer Cell  Volume 8, Issue 6, Pages 439-441 (December 2005) DOI: 10.1016/j.ccr.2005.11.008 Copyright © 2005 Elsevier Inc. Terms and Conditions

Figure 1 Summary of genetic alterations in melanomas from patients with varying degrees of sun exposure as reported by Curtin et al. Melanomas from skin with evidence of chronic sun damage, intermittent sun exposure without evidence of damage, and no significant exposure exhibit distinct genomic patterns of gain/amplification and loss/deletion and different BRAF/NRAS mutational spectrums. BRAF and NRAS mutations were mutually exclusive, as were BRAF/NRAS activating mutations and increased copies of CCND1 or CDK4. Gain/amplification of CDK4 was more commonly seen in melanomas from protected skin than in melanoma from sun-exposed skin, as was deletion/loss of the CDNK2A locus, which was observed exclusively in samples without CDK4 amplification. UV, ultraviolet light; WT, wild-type; MT, mutant; amp, amplification. Cancer Cell 2005 8, 439-441DOI: (10.1016/j.ccr.2005.11.008) Copyright © 2005 Elsevier Inc. Terms and Conditions